Bünger R, Mallet R T
Department of Physiology, F.E. Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4799.
Biochim Biophys Acta. 1993 Sep 19;1151(2):223-36. doi: 10.1016/0005-2736(93)90107-b.
Myocardial pyruvate oxidation is work- or calcium-load-related, but control of pyruvate dehydrogenase (PDH) by the specific mitochondrial pyruvate transporter has also been proposed. To test the transport hypothesis distribution of pyruvate across the cell membrane as well as rates of mitochondrial pyruvate net transport plus oxidation were examined in isolated perfused but stable and physiologically working guinea-pig hearts. 150 microM-1.2 mM alpha-cyanohydroxycinnamate proved to specifically block mitochondrial pyruvate uptake in these hearts. When perfusate glucose as cytosolic pyruvate precursor was supplied in combination with octanoate (0.2 or 0.5 mM) as diffusible alternative fatty acid substrate, alpha-cyanohydroxycinnamate produced up to 20- and 3-fold increases in pyruvate and lactate efflux, respectively. Cinnamates did not alter myocardial hemodynamics nor sarcolemmal pyruvate and lactate export. In contrast the tested concentrations of cinnamate produced reversible, dose-dependent decreases in 14CO2 production from [1-14C]pyruvate or [U-14C]glucose by inhibiting mitochondrial pyruvate uptake. Linear least-squares estimates of available cinnamate-sensitive total pyruvate transport potential yielded rates close to 110 mumol/min per g dry mass at S0.5 approximately 120 microM, which compared reasonably well with literature values from isolated cardiac mitochondria. This transport potential was severalfold larger than total extractable myocardial PDH activity of approximately 32 mumol/min per g dry mass at 37 degrees C. Even when cytosolic pyruvate levels were in the lower physiologic range of about 90 microM, pyruvate oxidation readily kept pace with mitochondrial respiration over a wide range of workload and inotropism. Furthermore, dichloroacetate, a selective activator of PDH, stimulated pyruvate oxidation without affecting myocardial O2 consumption, regardless of the metabolic or inotropic state of the hearts. Consequently, little or no regulatory function with regard to pyruvate oxidation could be assigned to the native mitochondrial pyruvate carrier of the working heart. Therefore, mitochondrial pyruvate-H+ symport was the normal, highly efficient (rather than controlling) mechanism for pyruvate entry into the mitochondria where PDH regulation controlled pyruvate oxidation.
心肌丙酮酸氧化与工作负荷或钙负荷相关,但也有人提出通过特定的线粒体丙酮酸转运体来控制丙酮酸脱氢酶(PDH)。为了验证转运假说,我们在离体灌注但稳定且生理功能正常的豚鼠心脏中检测了丙酮酸跨细胞膜的分布以及线粒体丙酮酸净转运和氧化速率。结果表明,150微摩尔/升 - 1.2毫摩尔/升的α - 氰基 - 羟基肉桂酸能特异性阻断这些心脏中线粒体对丙酮酸的摄取。当将灌注液中的葡萄糖作为胞质丙酮酸前体与辛酸(0.2或0.5毫摩尔/升)作为可扩散的替代脂肪酸底物联合供应时,α - 氰基 - 羟基肉桂酸分别使丙酮酸和乳酸外流增加了20倍和3倍。肉桂酸盐不会改变心肌血流动力学以及肌膜丙酮酸和乳酸的输出。相反,所测试浓度的肉桂酸盐通过抑制线粒体丙酮酸摄取,使[1 - 14C]丙酮酸或[U - 14C]葡萄糖产生的14CO2产量出现可逆的、剂量依赖性降低。对可用的肉桂酸盐敏感的总丙酮酸转运潜能进行线性最小二乘法估计,在S0.5约为120微摩尔/升时,得到的速率接近110微摩尔/分钟每克干重,这与离体心脏线粒体的文献值相当吻合。这种转运潜能比在37℃时每克干重约32微摩尔/分钟的总可提取心肌PDH活性大几倍。即使胞质丙酮酸水平处于约90微摩尔/升的较低生理范围内,在广泛的工作负荷和变力状态下,丙酮酸氧化仍能轻松地与线粒体呼吸保持同步。此外,二氯乙酸作为PDH的选择性激活剂,无论心脏的代谢或变力状态如何,都能刺激丙酮酸氧化而不影响心肌耗氧量。因此,对于工作心脏的天然线粒体丙酮酸载体,几乎没有或没有赋予其对丙酮酸氧化的调节功能。所以,线粒体丙酮酸 - H + 同向转运是丙酮酸进入线粒体的正常、高效(而非控制)机制,其中PDH调节控制着丙酮酸氧化。